Deep Brain Stimulation for Parkinson Disease in the Philippines: Outcomes of the Philippine Movement Disorder Surgery Center

World Neurosurg. 2018 Jul:115:e650-e658. doi: 10.1016/j.wneu.2018.04.125. Epub 2018 Apr 28.

Abstract

Objective: Deep brain stimulation (DBS) is an established treatment modality for Parkinson disease (PD). The first DBS for PD in the Philippines was performed at the Philippine Movement Disorder Surgery Center in 2006. There are no Philippine data on DBS for PD. We aim to determine the motor improvement and reduction in medication dosage of all patients with PD who underwent DBS at the Philippine Movement Disorder Surgery Center.

Methods: This is a retrospective study of all patients with PD (n = 17) who underwent DBS from 2006 to 2016. The change in the Unified Parkinson's Disease Rating Scale (UPDRS) motor and levodopa equivalent dose were determined.

Results: There was a statistically significant reduction in the UPDRS motor in all patients off medication at 3 months (48.2%; P = 0.004), 1 year (47.3%; P = 0.026), 2 years (48.4%; P = 0.021), and 3 years (66.0%; P = 0.032) after DBS and on medication at 3 months (43.3%; P = 0.023), 6 months (24.7%; P = 0.053), and 1 year (38.1%; P = 0.033). A significant reduction in the dosage of PD medications was also seen until the second year of follow-up (52.3%; P < 0.001). Adverse events included an attempted suicide and a device-related infection.

Conclusions: DBS for PD improves the UPDRS motor score in the off-medication and on-medication state, with the maximal benefit seen at 3 years after surgery and reduces PD medication dosage by half. Although the benefit from DBS is undeniable, the high cost of the procedure precludes more patients from benefitting from it. There is a need for government support to expand access to DBS.

Keywords: Deep brain stimulation; Levodopa equivalent dose; Parkinson disease; Treatment outcomes.

MeSH terms

  • Adult
  • Deep Brain Stimulation / methods
  • Deep Brain Stimulation / trends*
  • Female
  • Follow-Up Studies
  • Hospitals, Private / trends*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / diagnosis
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / therapy*
  • Philippines / epidemiology
  • Retrospective Studies
  • Tertiary Care Centers / trends*
  • Treatment Outcome

Substances

  • Levodopa